Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in Previously Treated Subjects with Squamous Histology Non-Small Cell Lung Cancer
Phase: 3Phase III, 2Phase II in Spain, 1Phase I